Shennan, AndrewSuff, NatalieLeigh Simpson, JoeJacobsson, BoMol, Ben W.Grobman, WilliamFIGO Working Group for Preterm Birth2021-10-062021-10-062021-10-01Shennan, A, Suff, N, Leigh Simpson, J, Jacobsson, B, Mol, B W, Grobman, W & FIGO Working Group for Preterm Birth 2021, 'FIGO good practice recommendations on progestogens for prevention of preterm delivery', International Journal of Gynecology and Obstetrics, vol. 155, no. 1, pp. 16-18. https://doi.org/10.1002/ijgo.138520020-7292Jisc: 7f1d01a12b45470fbe8cdf62472c9c7ehttps://hdl.handle.net/2164/17277Funding Information: Andrew Shennan reports payment/honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Manipal India; support for attending meetings and/or travel from Hologic; leadership or fiduciary roles in the HTA Commissioning Board UK and Action on Pre‐eclampsia charity. Natalie Suff reports no conflicts of interest. Jo Leigh Simpson reports royalties from Springer and Elsevier; consulting fees from the Illumina Clinical Expert Panel 2020; payment or honoraria for lectures, presentations, speakers bureaus, or educational events from the 1 and 2 International Congresses on the Future of Women's Health, and a speaker's bureau at ASRM 2019; participation on a data safety monitoring board or advisory board for the FDA DSMB; and leadership or fiduciary roles in IFFS and PGDIS. Bo Jacobbson reports research grants from Swedish Research Council, Norwegian Research Council, March of Dimes, Burroughs Wellcome Fund and the US National Institute of Health; clinical diagnostic trials on NIPT with Ariosa (completed), Natera (ongoing), Vanadis (completed) and Hologic (ongoing) with expendidures reimbused per patient; clinical probiotic studies with product provided by FukoPharma (ongoing, no funding) and BioGaia (ongoing; also provided a research grant for the specific study); collaboration in IMPACT study where Roche, Perkin Elmer and Thermo Fisher provided reagents to PLGF analyses; coordination of scientific conferences and meetings with commercial partners as such as NNFM 2015, ESPBC 2016 and a Nordic educational meeting about NIPT and preeclampsia screening. Bo Jacobbson is also Chair of the FIGO Working Group for Preterm Birth and the European Association of Perinatal Medicine's special interest group of preterm delivery; steering group member of Genomic Medicine Sweden; chairs the Genomic Medicine Sweden complex diseases group; and is Swedish representative in the Nordic Society of Precision Medicine. Ben W. Mol reports an investigator grant from NHMRC; consultancy for ObsEva; and research funding from Guerbet, Ferring, and Merck KGaA. William A. Grobman reports no conflicts of interest. st nd3336854engantenatalchild outcomepreterm deliverypreventionprogesteroneR MedicineObstetrics and GynaecologyRJournal article10.1002/ijgo.13852http://www.scopus.com/inward/record.url?scp=85115098118&partnerID=8YFLogxK1551